Aptamers: A promising tool for cancer imaging, diagnosis, and therapy
Authors:
- 4 September 2012
- journal article
- prospects
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 114 (2) , 250-255
Abstract
Aptamers are a group of molecules, which can specifically bind, track, and inhibit target molecules, comprising DNA aptamers, RNA aptamers, and peptide aptamers. So far, there are much progress about developing novel aptamers and their expansile applications. This prospect systematically introduces the composition and technological evolution of aptamers, and then focuses on the application of aptamers in cancer diagnosis, imaging, and therapy. Following this, we discuss the potential to harness aptamers in discovering the biomarker of stem cells, which is favorable for us to study the normal developmental or abnormal pathological process of tissue and to deliver drugs into target cells or tissues in the future. J. Cell. Biochem. 114: 250–255, 2013.Keywords
This publication has 55 references indexed in Scilit:
- Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cellsSurgery, 2011
- Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alterationProceedings of the National Academy of Sciences, 2011
- Aptamer-Conjugated Nanoparticles for Cancer Cell DetectionAnalytical Chemistry, 2011
- Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cellsBritish Journal of Cancer, 2010
- The formulation of aptamer-coated paclitaxel–polylactide nanoconjugates and their targeting to cancer cellsBiomaterials, 2010
- Aptamer−Nanoparticle Strip Biosensor for Sensitive Detection of Cancer CellsAnalytical Chemistry, 2009
- RNA Aptamer Blockade of Osteopontin Inhibits Growth and Metastasis of MDA-MB231 Breast Cancer CellsMolecular Therapy, 2009
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticlesProceedings of the National Academy of Sciences, 2008
- Cell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer CellsJournal of Proteome Research, 2008
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences, 2006